Multiracial Cytokine Profiling Reveals Immune Dysregulation not Chronic Inflammation in Polycystic Ovary Syndrome
The Journal of Clinical Endocrinology & Metabolism · 2026
DOI: 10.1210/clinem/dgaf524 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Gabriela Pacheco-Sanchez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Biochemistry, School of Biological Sciences, University of California Irvine, Irvine, CA 92697, USA. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Inflammation, Cytokines. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, UCLA LIFT-UP, Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Context
Polycystic ovary syndrome (PCOS) is a common endocrine disorder often associated with chronic inflammation, but comprehensive characterization of immune markers across diverse patient populations is lacking.
Objective
To determine whether PCOS exhibits a profile of chronic inflammation or immune dysregulation when analyzed across a diverse patient population.
Design
Retrospective cross-sectional study of samples collected between 1987 and 2010 as part of the Androgen Excess Biorepository.
Setting
Reproductive endocrinology clinics at the University of Alabama at Birmingham in Birmingham, Alabama, and Cedars-Sinai Medical Center in Los Angeles, California, where women and adolescents presented for evaluation of androgen excess. Patients Forty premenopausal women (20 with PCOS, 20 controls) aged 18 to 45 years, categorized by race (Black and White) and PCOS diagnosis. Participants were race, age, and body mass index matched. Main Outcome Measures Fasted follicular phase plasma concentrations of C-reactive protein and 96 circulating immune markers, including interleukin (IL)-6, tumor necrosis factor-α (TNF-α), and IL-18, measured using a Milliplex Luminex xMAP assay.
Results
PCOS patients showed significantly lower levels of circulating immune markers (P < .05). Growth factors (vascular endothelial growth factor A, platelet-derived growth factor), proinflammatory cytokines (IL-8, TNF-α, interferon-γ), and several chemokines were reduced in PCOS patients, independent of race. Only IL-18 and C-X-C motif chemokine ligand 16 showed statistically significant differences between Black and White women.
Conclusion
This study challenges the prevailing notion of PCOS as a disorder of chronic low-grade inflammation, suggesting instead that immune suppression and impaired angiogenic signaling may be factors in PCOS pathophysiology, especially in nonobese patients. Further research with larger sample sizes and inclusion of metabolic metrics is needed to confirm these findings before they can be applied in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biology and Biochemistry, School of Biological Sciences, University of California Irvine, Irvine, CA 92697, USA.
- Keck Graduate Institute, Claremont, CA 91711, USA.
- Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
- Department of Health Policy, Management and Behavior, School of Public Health, University at Albany, State University of New York, Albany, NY 12222, USA.
- Department of Obstetrics and Gynecology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35249, USA.
- Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35249, USA.
ORCID-Profile: Gabriela Pacheco-Sanchez, Ricardo Azziz, Dequina A Nicholas, Jessica L Chan
Förderung
- NICHD NIH HHS
- UCLA LIFT-UP
- Diabetes and Digestive and Kidney Diseases
- NIH HHS
- National Institutes of Health
- National Institute of Child Health and Human Development
Zitieren
APA
Pacheco-Sanchez, G., Herrera, R., Pisarska, M. D., Azziz, R., Nicholas, D. A., & Chan, J. L. (2026). Multiracial Cytokine Profiling Reveals Immune Dysregulation not Chronic Inflammation in Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf524
Vancouver
Pacheco-Sanchez G, Herrera R, Pisarska MD, Azziz R, Nicholas DA, Chan JL. Multiracial Cytokine Profiling Reveals Immune Dysregulation not Chronic Inflammation in Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgaf524
BibTeX
@article{PachecoSanchez2026,
author = {Pacheco-Sanchez, Gabriela and Herrera, Rebecca and Pisarska, Margareta D and Azziz, Ricardo and Nicholas, Dequina A and Chan, Jessica L},
title = {Multiracial Cytokine Profiling Reveals Immune Dysregulation not Chronic Inflammation in Polycystic Ovary Syndrome},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
doi = {10.1210/clinem/dgaf524}
}
EUVIMED